Nalaganje...
New combination strategies using PD-1/ L1 checkpoint inhibitors as a backbone
The discovery of immune checkpoints and subsequent clinical development of checkpoint inhibitors has revolutionized the field of oncology. The durability of the anti-tumor immune responses has raised the hope for long term patient survival and potential cure; however, currently only a minority of pa...
Shranjeno v:
| izdano v: | Cancer J |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5844278/ https://ncbi.nlm.nih.gov/pubmed/28114250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000246 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|